Noxxon announces launch of capital increase right issue for an amount of up to € 3.9 m
CEST - NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX, the “Company”), a biotechnology company focused on improving ca…
CEST - NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX, the “Company”), a biotechnology company focused on improving ca…
Aurania Resources Ltd. (TSX-V: ARU) (“Aurania” or the “Company” - https://www.youtube.com/... ) is pleased to announce…
Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announce…
Sonova Holding AG, the world’s leading provider of hearing solutions, today announces its results for the first half of…
DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced that enrollment for P…
Sonova Holding AG today holds its second annual Investor & Analyst Day at its headquarter in Staefa, Switzerland. The ev…
YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances…
YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commerc…
YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commerc…
YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commerc…